Nasdaq

India's Biocon in talks with Mylan to merge biosimilar businesses - Moneycontrol

Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news website Moneycontrol reported on Thursday, citing sources with direct ...
Business Insider

Mylan and Biocon Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada

HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, April 28, 2020 /CNW/ -- Mylan N.V. and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the launch of Fulphila ®, a biosimilar to ...
Morningstar

Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options

BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...
Business Insider

Just - Evotec Biologics & Biocon Biologics Sign Licensing Deal For A Biosimilar Asset

BIOCON BIOLOGICS IN-LICENSES AN EARLY-STAGE BIOSIMILAR ASSET, WILL UNDERTAKE DEVELOPMENT, MANUFACTURING AND COMMERCIALISATION UNDER ITS OWN LABEL JUST - EVOTEC BIOLOGICS HAS RECEIVED A LICENSE FEE AND ...
Morningstar

Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars

BENGALURU, India and BRIDGEWATER, N.J., Sept. 17, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of ...